Oaktree Acquisition Corp. III Life Sciences
NASDAQ:OACCShell Companies
+$0.00 today
- Market cap
- $263.53M
- Beta
- -0.04
- P/E (TTM)
- 29.1
- EPS (TTM)
- $0.37
Volume 0.00M
Average 0.01M
OACC Net Change in Cash
Combined operating, investing, financing, and currency effects on the cash balance during the period.
Oaktree Acquisition Corp. III Life SciencesNASDAQ: OACC
Net Change in Cash · Q1 FY2026 · quarter ended Mar 2026
Net change in cash of -$158.04K in Q1 FY2026
Q1 FY2026 net change in cash was -$158.04K.
Sources:Cash FlowText generated from reported figures; not investment advice.
Net Change in Cash history
USD · from the cash flow
- Latest · FY2025
- 77.92K USD
- Year-over-year change
- -94.3%
- 1-year CAGR
- -94.3%
| Period | Period end | Net Change in Cash | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 77.92K | -94.3% |
| FY2024 | 2024-12-31 | 1.36M | — |
Net Change in Cash vs competitors
How OACC compares with its peers on the latest reported figures
- OACC's FY2025 net change in cash of $77.92K is the 6th largest of the 10 companies compared; the peer median is $53.12K.
- Its year-over-year change of -94.3% is the 2nd highest of 4, against a peer median of -155.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| FY2025 | $930.71K | -167.3% | +128.1% | — | |
| LTM Mar 2026 | $809.12K | -155.5% | +64.0% | — | |
| FY2025 | $624.16K | — | — | — | |
| LTM Sep 2025 | $551.2K | — | — | — | |
| LTM Mar 2026 | $503.43K | — | — | — | |
OACCOaktree Acquisition Corp. III Life Sciences | FY2025 | $77.92K | -94.3% | — | — |
MBAVM3-Brigade Acquisition V Corp. Class A Ordinary shares | LTM Mar 2026 | $57.44K | -93.0% | — | — |
COPLCopley Acquisition Corp | LTM Mar 2026 | $54.65K | — | — | — |
| LTM Mar 2026 | $53.12K | — | — | — | |
AACBArtius II Acquisition Inc. Class A Ordinary Shares | FY2025 | $32.19K | — | — | — |
| Peer median (excluding OACC) | $53.12K | -155.5% | +96.1% | — | |
Competitors are the stored peer set for OACC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|
| Net Income | 2.66K | 7.29M |
| Depreciation & Amortization | 0 | 0 |
| Deferred Income Tax | 0 | 0 |
| Stock-Based Compensation | 0 | 0 |
| Change in Working Capital | (629) | 0 |
| Accounts Receivables | 0 | 0 |
| Inventory | 0 | 0 |
| Accounts Payables | 0 | (33.55K) |
| Other Working Capital | (629) | 0 |
| Other Non-Cash Items | (91.72K) | (7.71M) |
| Operating Cash Flow | (179) | (422.08K) |
| Capital Expenditures | (3) | 0 |
| Acquisitions (Net) | 0 | 0 |
| Purchases of Investments | (191.99M) | 0 |
| Sales of Investments | 0 | 0 |
| Other Investing Activities | 0 | 500K |
| Investing Cash Flow | (191.99M) | 500K |
| Debt Repayment | (551.14K) | 0 |
| Common Stock Issued | 193.99M | 0 |
| Common Stock Repurchased | 0 | 0 |
| Dividends Paid | 0 | 0 |
| Other Financing Activities | 0 | 0 |
| Financing Cash Flow | 193.44M | 0 |
| Effect of Forex Changes | 0 | 0 |
| Net Change in Cash | 1.36M | 77.92K |
| Free Cash Flow | (179) | (422.08K) |
Oaktree Acquisition Corp. III Life Sciences
NASDAQ:OACC
Intrinsic Alpha fair value
Locked
Current Price
$10.72
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.